Device Trial Radar · NCT05468931
Prostate Stimulation for Sexual Dysfunction
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
15
Planned (sponsor's estimate)
Start
Apr 18, 2024
Primary completion
Jun 1, 2027
Study completion Jun 1, 2027
Sponsor
- Lead sponsor
- Stanford UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jul 21, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- FDA-regulated device
- No
- Who can join
- Male only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to use a device to stimulate the prostate with a goal of helping improve symptoms in men with sexual dysfunction.
Conditions
- Sexual Dysfunction
- Erectile Dysfunction
- Delayed Ejaculation
- Anorgasmia
Interventions
Prostate stimulatorDevice
Prostate stimulation device for sexual dysfunction
Primary outcomes
What the sponsor says the trial is designed to measure.
- change in modified International Index of Erectile Dysfunction scoreTime frame: baseline and up to 1 month post-baseline
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Stanford Healthcare, Stanford Hospital
Stanford, California · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.